Trustees’ Annual Report for the period
From 01 April 2024 To 31 March 2025
Charity name: Liverpool International transplant Initiative
Charity registration number: 1157311
Objectives and Activities
| SORP reference | ||
|---|---|---|
| Summary of the purposes of the charity as set out in its governing document |
Para 1.17 | 1. To promote transplantation in underprivileged countries. 2. To facilitate the creation of transplant units in these countries, including equipment and expertise. 3. To help train local healthcare professionals in the field of transplant. 4. To support travelling teams from Liverpool to train and educate healthcare professionals in the field of transportation. |
| Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts. |
Para 1.17 and 1.19 |
Since its inception, the main activity of the charity has been its work with Al Shifa Hospital, Gaza. The collaborative charitable initiative between these two organisations aims to establish a kidney transplant programme serving the population of Gaza. The specific aims of this project are to: Establish a kidney transplantation programme at Al Shifa Hospital in Gaza Establish the framework which will regulate transplant activity in Gaza Over the life of the project the long and short-term objectives have been as follows: Long term plan is to establish a kidney transplant programme in Gaza run by local expertise. To continue transplant activity with the support from the Royal Liverpool Hospital Transplant Unit until the Gaza programme is fully independent. This involves consultant transplant surgeons and associated medical staff travelling to Gaza to carry out surgery and provide expert teaching and |
| advice. | ||
|---|---|---|
| Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit |
Para 1.18 | Trustees have had regard to the guidance issued by the Charity commission on public benefit. |
| Additional information (optional) You may choose to include further statements where relevant about: |
||
| SORP reference | ||
| Policy on grant making | Para 1.38 | |
| Policy on social investment including program related investment |
Para 1.38 | |
| Contribution made by volunteers |
Para 1.38 | |
| Other | Due to the current situation in Gaza the work of the Charity has been suspended and we await a resolution before any decision on the future of our work can be made. |
Achievements and Performance
| SORP reference | ||
|---|---|---|
| Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole. |
Para 1.20 | Dialysis for end stage renal failure represents a huge burden on society and healthcare budget. Transplantation offers a better quality of life for patients with end stage renal failure and a better chance of being productive and keeping a job. Also it offers longer survival in comparison to dialysis. It is estimated that each dialysis patient costs around $25-30.000 US dollars per year. The course of kidney transplantation is estimated at around $25,000 dollars for the first year and then $3-5,000 dollars per year afterwards. Kidney transplantation is the best treatment option for patients with end stage renal failure. Literature evidence indicates that kidney transplantation offers a better quality of life compared to dialysis and prolonged survival. Also it is established that kidney transplantation is the |
most cost effective modality of treatment of kidney failure. The number of patients who are on dialysis in Gaza are around 350 patients. Currently patients who require kidney transplantation have to travel abroad to have the procedure performed with an estimated cost of around $25,000 US dollars per patient. For most patients in Gaza that is not a viable option. With the Gaza population of 2 million plus it is estimated that the need for kidney transplantation is around 75 transplants per year.
Additional information (optional) You may choose to include further statements where relevant about:
Achievements against objectives set |
Para 1.41 |
This is a long term project set against a background of political and funding issues. However, to date there have been over 80 successful transplants performed by the team providing incalculable benefits for those patients and the training for clinicians in Gaza continues. |
|---|---|---|
| Performance of fundraising activities against objectives set |
Para 1.41 | There are no specific fund raising activities. |
| Investment performance against objectives |
Para 1.41 | No Investments exist. |
| Other | The only activity during this period was the purchase of anti rejection medications which were supplied to clinicians able to access patients within the occupied territories. |
Financial Review
| Financial Review | ||
|---|---|---|
| Review of the charity’s financial position at the end of the period |
Para 1.21 | The Charity is funded on a voluntary basis and only travel expenses are paid if the funding exists. |
| Statement explaining the policy for holding reserves stating why they are held |
Para 1.22 | No Policy exists |
| Amount of reserves held | Para 1.22 | Nil |
| Reasons for holding zero reserves |
Para 1.22 | Not Required |
| Details of fund materially in deficit |
Para 1.24 | N/A |
| Explanation of any uncertainties about the charity continuing as a going concern |
Para 1.23 | - |
Additional information (optional) You may choose to include further statements where relevant about:
The charity’s principal sources of funds (including any fundraising) |
Para 1.47 |
Donations |
|---|---|---|
| Investment policy and objectives including any social investment policy adopted |
Para 1.46 | None |
| A description of the principal risks facing the charity |
Para 1.46 | Access to Gaza is via permits obtained through the WHO. Without these the work could not continue. Within Gaza access to staff and hospital facilities is provided by the Gaza Ministry of Health as required. |
| Other | Since November 2023, no access to Gaza has been possible and the work of the charity has been suspended. |
Structure, Governance and Management
| Description of charity’s trusts: |
None | |
|---|---|---|
| Type of governing document (trust deed, royal charter) |
Para 1.25 | |
| How is the charity constituted? (e.g unincorporated association, CIO) |
Para 1.25 | |
| Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees |
Para 1.25 |
Additional information (optional)
You may choose to include further statements where relevant about:
Policies and procedures adopted for the induction and training of trustees |
Para 1.51 |
|
|---|---|---|
| The charity’s organisational structure and any wider network with which the charity works |
Para 1.51 | |
| Relationship with any related parties |
Para 1.51 | |
| Other |
Reference and Administrative details
| Charity name | Liverpool International transplant Initiative |
|---|---|
| Other name the charity uses | None |
| Registered charity number | 1157311 |
| Charity’s principal address | Ward 9c, Royal Liverpool University Hospital, Prescot street , Liverpool, L7 8XP |
Names of the charity trustees who manage the charity
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Trustee name | Office (if any) | Dates acted if not for whole year |
|---|---|---|---|
| Mr A Hammad | Chaiman | ||
| Mr E Scraggs | Secretary/Trustee | ||
| Mr C McKean | Trustee | ||
– Corporate trustees names of the directors at the date the report was approved Director name
Name of trustees holding title to property belonging to the charity
Trustee name Dates acted if not for whole year
Funds held as custodian trustees on behalf of others
Description of the assets None held in this capacity Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects
Details of arrangements for safe custody and segregation of such assets from the charity’s own assets
Additional information (optional)
Names and addresses of advisers (Optional information)
Type of adviser Name
Name of chief executive or names of senior staff members (Optional information)
Exemptions from disclosure
Reason for non-disclosure of key personnel details
Other optional information
Declarations
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
Signature(s) Saray, Full name(s) Mr E F Scraggs ~~pO~~ Position (eg Secretary, Chair, etc) ~~pO~~ Secretary/Trustee Date 01/05/26 ~~po~~
Section A Receipts and payments
A1 Receipts Brought forward Donations
Sub total(Gross income for AR)
A2 Asset and investment sales, (see table).
Sub total
Total receipts
A3 Payments Bank Charges Medication purchased
Sub total
A4 Asset and investment purchases, (see table)
Sub total
Total payments
Net of receipts/(payments) A5 Transfers between funds A6 Cash funds last year end Cash funds this year end
Section B Statement of assets and liabilities at the end of the period
Page 1
Categories
B1 Cash funds
B2 Other monetary assets
B3 Investment assets
B4 Assets retained for the charity�s own use
B5 Liabilities
Signed by one or two trustees on behalf of all the trustees
Page 2
| Charity Name | |||
|---|---|---|---|
| Liverpool International Transplant Initiative | |||
| Receipts and payments accounts | |||
| For the period | from | Period start date | |
| 01/04/24 | |||
| Unrestricted funds | Restricted funds | ||
| to the nearest | � |
to the nearest� | |
| 10620 | - | ||
| 3500 | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| 14120 | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| 14120 | - | ||
| 72 | - | ||
| 9129 | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| 9201 | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| 9201 | - | ||
| 4919 | - | ||
| - | - | ||
| - | - | ||
| 4919 | - |
Page 3
Details
Total cash funds (agree balances with receipts and payments account(s))
Details Details Details Details Signature
Page 4
No (if any) 1157311
| To | Period end date | ||
|---|---|---|---|
| 31/03/25 | |||
| Endowment funds | Total funds | ||
| to the nearest� | to the nearest� | ||
| - | 10620 | ||
| - | 3500 | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | 14120 | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | 14120 | ||
| - | 72 | ||
| - | 9129 | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | 9201 | ||
| - | - | ||
| - | - | ||
| - | - | ||
| - | 9201 | ||
| - | 4919 | ||
| - | - | ||
| - | - | ||
| - | 4919 |
Page 5
| Unrestricted funds | Restricted funds |
|---|---|
| to nearest� | to nearest� |
| - | - |
| - | - |
| - | - |
| - | - |
| Agreement Error | OK |
| Unrestricted funds | Restricted funds |
| to nearest� | to nearest� |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Fund to which asset belongs | Cost (optional) |
| - | |
| - | |
| - | |
| - | |
| - | |
| Fund to which asset belongs | Cost (optional) |
| - | |
| - | |
| - | |
| - | |
| - | |
| - | |
| - | |
| - | |
| - | |
| Fund to which liability relates | Amount due (optional) |
| - | |
| - | |
| - | |
| - | |
| - | |
| Print Name | |
| Mr E F Scraggs | |
| Mr Abdul Hammad |
Page 6
CC16a
Last year to the nearest � - - - - - - - -
Page 7
Endowment funds to nearest � - - - - OK Endowment funds to nearest � - - - - - -
Current value (optional)
Current value (optional)
When due (optional)
Date of approval
05/01/26 05/01/26
Page 8